Home    Contact    Sitemap    Search    
  Print page    
  

2012.02.02   Photocure’s partner Ipsen announces 4Q 11 Hexvix® sales in Germany and Italy  [Stock Exchange Notice]
2012.01.13   Photocure announces completion of Visonac® study enrolment  [Stock Exchange Notice]
2012.01.09   Photocure ASA - Photocure strengthens the Management Team  [Stock Exchange Notice]
2012.01.03   Photocure ASA - Cevira Study completes study enrolment on time  [Stock Exchange Notice]
2011.12.30   Photocure ASA: Photocure Announces Transfer of Marketing Authorisation for Cysview in the USA  [Stock Exchange Notice]
2011.12.05   Photocure - repurchase program of own shares  [Press Release][Stock Exchange Notice]
2011.12.05   Photocure presenting at Nordic health care conference 2011  [Press Release][Stock Exchange Notice]
2011.11.29   Photocure appoints interim Chief Financial Officer  [Press Release][Stock Exchange Notice]
2011.11.28   Photocure nominates market maker on oslo stock exchange  [Press Release][Stock Exchange Notice]
2011.11.18   Photocure announces resignment of Chief Financial Officer  [Press Release][Stock Exchange Notice]
2011.11.07   3rd Quarter Report 2011  [Stock Exchange Notice]
2011.10.24   Invitation to a presentation of the 3rd quarter report 2011  [Stock Exchange Notice]
2011.10.14   Photocure announces the achievement of the first transition milestone of Eur 2.0 million for Hexvix®  [Press Release][Stock Exchange Notice]
2011.09.27   Photocure announces new commercial strategy for Hexvix®, the innovative product for improved detection of bladder cancer  [Stock Exchange Notice]
2011.08.22   From NBC - Cysview and cancer detection  [Stock Exchange Notice]
2011.08.18   Presentation of the 2nd Quarter results 2011  [Stock Exchange Notice]
2011.07.18   Photocure initiates enrollment into phase II trial of Visonac® for treatment of moderate to severe acne  [Stock Exchange Notice]
2011.06.22   Photocure Launches Allumera® A New, Dynamic Cosmetic For Achieving Timeless Skin  [Press Release][Stock Exchange Notice]
2011.06.22   Photocure initiates enrollment into phase II trial of Cevira® for cervical HPV infection  [Press Release][Stock Exchange Notice]
2011.05.30   Photocure Announces First Commercial Sale of Allumera® in the US  [Press Release][Stock Exchange Notice]
2011.05.12   Hexvix®/Cysview(TM) demonstrates long term benefit  [Stock Exchange Notice]
2011.05.12   Photocure Strengthens the Management Team  [Press Release][Stock Exchange Notice]
2011.05.12   Photocure Announces Key Changes to the Board of Directors  [Press Release][Stock Exchange Notice]
2011.04.26   Presentation of the 1st Quarter 2011 Report  [Press Release][Stock Exchange Notice]
2011.04.05   Notice of annual general meeting  [Stock Exchange Notice]


 
  Photocure ASA, Hoffsveien 4, NO-0275 Oslo, Norway. Telephone: +47 22 06 22 10 Fax: +47 22 06 22 18